Navigation Links
Poniard Pharmaceuticals Awarded $244,479 Grant Under Qualifying Therapeutic Discovery Project Program
Date:11/4/2010

n to focus its resources on the continued development of picoplatin, the Company's assessment of the commercial and therapeutic potential of picoplatin, the Company's plan to explore strategic alternatives to support the continued development of picoplatin, and the Company's goal of optimizing and realizing shareholder value from picoplatin. Actual results and events may differ materially from those indicated in these forward-looking statements based on a number of factors, including risks and uncertainties inherent in the Company's business, including the Company's anticipated future operating losses, need for future capital and ability to obtain future funding on favorable terms or at all; the risk that strategic relationships may not be established on a timely basis, on terms that are ultimately favorable to the Company, or at all; the potential safety, efficacy and commercial viability of picoplatin; the risk that the Company's additional analyses of data from clinical trials of picoplatin may produce negative or inconclusive results, or may be inconsistent with previously announced results or previously conducted trials; the Company's ability to retain key personnel; competition from third parties; the Company's ability to preserve and protect its intellectual property rights; the Company's dependence on third-party manufacturers, suppliers and other contractors; changes in technology, government regulation and general market conditions; the receipt and timing of FDA and other required regulatory approvals, if at all; and the risks and uncertainties described in the Company's current and periodic reports filed with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the year ended December 31, 2009 and its Quarterly Report on Form 10-Q for the quarter ended June 30, 2010. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company u
'/>"/>
SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
7. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
11. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... India , July 4, 2015 ... continue cible les épidémies que sont l,hypertension, le ... et du Sud-Est, par l,intermédiaire de plateformes éducatives ... maladies.      (Photo: http://photos.prnewswire.com/prnh/20150630/227090 ... en charge le diabète en ligne , ...
(Date:7/3/2015)... MUMBAI , July 3, 2015 /PRNewswire/ ... gab heute bekannt, vorbehaltlich bestimmter Abschlussbedingungen eine ... Russland erworben zu haben. Mit dieser Übernahme ... der mit einem Umsatz von 765 Mrd. ... größten Pharmamärkten der Welt gehörte (IMS Health). ...
(Date:7/2/2015)... CHAPEL HILL, N.C. , July 2, 2015 ... their own employees to capture critical product and ... there are many benefits to employee-based studies, it ... to leverage their own internal employees to capture ... recent study by benchmarking firm, Best Practices, LLC, ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 3Lupin übernimmt Biocom aus Russland 2Lupin übernimmt Biocom aus Russland 3Leveraging Employee Insights to Produce Cutting-Edge Market Research 2
... Holdings, Inc. (OTC Bulletin Board: ... discovery, development and commercialization of novel drugs in the ... announced that the company provided testimony at the U.S. ... Human Services (HHS) Hearing on  "Defending Against Public Health ...
... ALEXANDRIA, Va., Oct. 4 The ... new division of the association dedicated to advancing ... (Logo:   http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ) ... is recognized as the advocate for independent community ...
Cached Medicine Technology:Advanced Life Sciences Offers Testimony at Senate Hearing on Defending Against Public Health Threats 2Advanced Life Sciences Offers Testimony at Senate Hearing on Defending Against Public Health Threats 3Advanced Life Sciences Offers Testimony at Senate Hearing on Defending Against Public Health Threats 4NCPA Announces New Division Dedicated to Long-Term Care Pharmacies, Patients 2NCPA Announces New Division Dedicated to Long-Term Care Pharmacies, Patients 3
(Date:7/3/2015)... ... July 03, 2015 , ... Brendon Burchard's new ... buzz of media attention. In an effort to spread the news, a comprehensive ... "These days many people are feeling overwhelmed by stress and fatigue," reports Hendricks. ...
(Date:7/3/2015)... Kan. (PRWEB) , ... July 03, 2015 , ... ... dedicated exclusively to healthcare providers, has been retained to lead a national ... top-ranked executive search firms in the healthcare industry, B. E. Smith has recently ...
(Date:7/3/2015)... ... July 03, 2015 , ... Jennifer Renee Hanes, DO is the ... , the largest network of independent freestanding emergency rooms in the United States. , ... our Sienna Plantation facility,” said Executive Medical Director of First Choice Emergency Room, Dr. ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Celebrity Dresses is currently running a promotion ... of celebrities will have the opportunity to get 10% discount on orders that are ... do not have to use coupon codes or remember redemption codes. , There ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... for her introduction of the Stop Overdose Stat (S.O.S.) Act of 2015 on ... Reed (D-R.I.), this Act seeks to decrease drug overdose – especially of heroin ...
Breaking Medicine News(10 mins):Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3
... the psychosocial effects of cleft lip and/or palate among ... predictor of behavioral problems. This study is published in ... ,The study included 160 children and young adults with ... no clefting. Anxiety, self-esteem, depression, behavioral problems, unhappiness with ...
... CRT (cardiac resynchronization therapy) known to be effective in ... death// is also proven for its benefits to diabetic ... the body, is capable of resynchronising the contractions of ... blood is pumped with added efficiency. It is estimated ...
... has led to the development of proposals to dump about 800 ... end of the month. ,The move follows the ... six months should stay on a list. ,Patients ... within six months are referred back to their GP for monitoring. ...
... Disorder (ADHD) cannot sit calmly at one place, pipe ... parents are familiar with the symptoms, the treatment of ... ,The FDA has given instructions that ADHD medication such ... warnings about the possible side effects like heart problems, ...
... spread of a rare HIV-2 virus. // ,Japanese ... against the rare HIV-2 form of the AIDS-causing virus after ... infected. ,An official of the health Ministry, ... question the local health authorities to submit written reports as ...
... be prevented if carbon monoxide is used, according ... paper called "Carbon monoxide inhibits // hypoxia/reoxygenation-induced apoptosis ... published in the September issue of The American ... pregnancy-associated hypertension, affects 5-7% of pregnancies and poses ...
Cached Medicine News:Health News:800 Patients to be Dumped from Hospital Waiting Lists 2Health News:Alternative therapies for ADHD 2Health News:Alternative therapies for ADHD 3Health News:Carbon Monoxide May Prevent Pre-Eclampsia 2
... A fixed pipette is ideal ... single volume. Fixed volume FInnpipettes ... advantages as other Finnpipette Digital ... Super blow-out (1-40ul), Soft-touch tip ...
... The Research Family includes fixed-volume, ... as the electronic Eppendorf Research pro ... button, these compact, high-performance pipettes have ... Optimally suited for use with original ...
... 2000 Pipette is a synonym for pipetting ... robust design, and superior operating comfort. Its ... the measuring stroke and blow-out as well ... system ensures utmost accuracy and precision. Ejection ...
1L...
Medicine Products: